1
|
Ren X, Wang X, Zheng G, Wang S, Wang Q, Yuan M, Xu T, Xu J, Huang P, Ge M. Targeting one-carbon metabolism for cancer immunotherapy. Clin Transl Med 2024; 14:e1521. [PMID: 38279895 PMCID: PMC10819114 DOI: 10.1002/ctm2.1521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Revised: 11/15/2023] [Accepted: 12/10/2023] [Indexed: 01/29/2024] Open
Abstract
BACKGROUND One-carbon (1C) metabolism is a metabolic network that plays essential roles in biological reactions. In 1C metabolism, a series of nutrients are used to fuel metabolic pathways, including nucleotide metabolism, amino acid metabolism, cellular redox defence and epigenetic maintenance. At present, 1C metabolism is considered the hallmark of cancer. The 1C units obtained from the metabolic pathways increase the proliferation rate of cancer cells. In addition, anticancer drugs, such as methotrexate, which target 1C metabolism, have long been used in the clinic. In terms of immunotherapy, 1C metabolism has been used to explore biomarkers connected with immunotherapy response and immune-related adverse events in patients. METHODS We collected numerous literatures to explain the roles of one-carbon metabolism in cancer immunotherapy. RESULTS In this review, we focus on the important pathways in 1C metabolism and the function of 1C metabolism enzymes in cancer immunotherapy. Then, we summarise the inhibitors acting on 1C metabolism and their potential application on cancer immunotherapy. Finally, we provide a viewpoint and conclusion regarding the opportunities and challenges of targeting 1C metabolism for cancer immunotherapy in clinical practicability in the future. CONCLUSION Targeting one-carbon metabolism is useful for cancer immunotherapy.
Collapse
Affiliation(s)
- Xinxin Ren
- Department of Head and Neck SurgeryOtolaryngology & Head and Neck Center, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital)Hangzhou Medical CollegeHangzhouZhejiangChina
- Key Laboratory of Endocrine Gland Diseases of Zhejiang ProvinceHangzhouZhejiangChina
- Zhejiang Provincial Clinical Research Center for Malignant TumorHangzhouZhejiangChina
- Department of PathologyCancer CenterZhejiang Provincial People's Hospital (Affiliated People's Hospital)Hangzhou Medical CollegeHangzhouZhejiangChina
| | - Xiang Wang
- Department of PharmacyAffiliated Hangzhou First People's HospitalZhejiang University School of MedicineHangzhouZhejiangChina
| | - Guowan Zheng
- Department of Head and Neck SurgeryOtolaryngology & Head and Neck Center, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital)Hangzhou Medical CollegeHangzhouZhejiangChina
- Key Laboratory of Endocrine Gland Diseases of Zhejiang ProvinceHangzhouZhejiangChina
- Zhejiang Provincial Clinical Research Center for Malignant TumorHangzhouZhejiangChina
| | - Shanshan Wang
- Department of PharmacyCenter for Clinical PharmacyCancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical CollegeHangzhouZhejiangChina
| | - Qiyue Wang
- Department of Head and Neck SurgeryOtolaryngology & Head and Neck Center, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital)Hangzhou Medical CollegeHangzhouZhejiangChina
- Key Laboratory of Endocrine Gland Diseases of Zhejiang ProvinceHangzhouZhejiangChina
- Zhejiang Provincial Clinical Research Center for Malignant TumorHangzhouZhejiangChina
| | - Mengnan Yuan
- Department of PharmacyCenter for Clinical PharmacyCancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical CollegeHangzhouZhejiangChina
| | - Tong Xu
- Department of PharmacyCenter for Clinical PharmacyCancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical CollegeHangzhouZhejiangChina
| | - Jiajie Xu
- Department of Head and Neck SurgeryOtolaryngology & Head and Neck Center, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital)Hangzhou Medical CollegeHangzhouZhejiangChina
- Key Laboratory of Endocrine Gland Diseases of Zhejiang ProvinceHangzhouZhejiangChina
- Zhejiang Provincial Clinical Research Center for Malignant TumorHangzhouZhejiangChina
| | - Ping Huang
- Department of PharmacyCenter for Clinical PharmacyCancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical CollegeHangzhouZhejiangChina
| | - Minghua Ge
- Department of Head and Neck SurgeryOtolaryngology & Head and Neck Center, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital)Hangzhou Medical CollegeHangzhouZhejiangChina
- Key Laboratory of Endocrine Gland Diseases of Zhejiang ProvinceHangzhouZhejiangChina
- Zhejiang Provincial Clinical Research Center for Malignant TumorHangzhouZhejiangChina
| |
Collapse
|
2
|
van der Krift F, Zijlmans DW, Shukla R, Javed A, Koukos PI, Schwarz LLE, Timmermans-Sprang EP, Maas PE, Gahtory D, van den Nieuwboer M, Mol JA, Strous GJ, Bonvin AM, van der Stelt M, Veldhuizen EJ, Weingarth M, Vermeulen M, Klumperman J, Maurice MM. A novel antifolate suppresses growth of FPGS-deficient cells and overcomes methotrexate resistance. Life Sci Alliance 2023; 6:e202302058. [PMID: 37591722 PMCID: PMC10435995 DOI: 10.26508/lsa.202302058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Revised: 08/07/2023] [Accepted: 08/07/2023] [Indexed: 08/19/2023] Open
Abstract
Cancer cells make extensive use of the folate cycle to sustain increased anabolic metabolism. Multiple chemotherapeutic drugs interfere with the folate cycle, including methotrexate and 5-fluorouracil that are commonly applied for the treatment of leukemia and colorectal cancer (CRC), respectively. Despite high success rates, therapy-induced resistance causes relapse at later disease stages. Depletion of folylpolyglutamate synthetase (FPGS), which normally promotes intracellular accumulation and activity of natural folates and methotrexate, is linked to methotrexate and 5-fluorouracil resistance and its association with relapse illustrates the need for improved intervention strategies. Here, we describe a novel antifolate (C1) that, like methotrexate, potently inhibits dihydrofolate reductase and downstream one-carbon metabolism. Contrary to methotrexate, C1 displays optimal efficacy in FPGS-deficient contexts, due to decreased competition with intracellular folates for interaction with dihydrofolate reductase. We show that FPGS-deficient patient-derived CRC organoids display enhanced sensitivity to C1, whereas FPGS-high CRC organoids are more sensitive to methotrexate. Our results argue that polyglutamylation-independent antifolates can be applied to exert selective pressure on FPGS-deficient cells during chemotherapy, using a vulnerability created by polyglutamylation deficiency.
Collapse
Affiliation(s)
- Felix van der Krift
- Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Dick W Zijlmans
- Department of Molecular Biology and Oncode Institute, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - Rhythm Shukla
- NMR Spectroscopy, Bijvoet Centre for Biomolecular Research, Department of Chemistry, Faculty of Science, Utrecht University, Utrecht, The Netherlands
| | - Ali Javed
- NMR Spectroscopy, Bijvoet Centre for Biomolecular Research, Department of Chemistry, Faculty of Science, Utrecht University, Utrecht, The Netherlands
- Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Utrecht University, Utrecht, The Netherlands
| | - Panagiotis I Koukos
- Computational Structural Biology, Bijvoet Centre for Biomolecular Research, Faculty of Science, Department of Chemistry, Utrecht University, Utrecht, The Netherlands
| | - Laura LE Schwarz
- Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands
| | | | - Peter Em Maas
- Specs Compound Handling B.V., Zoetermeer, The Netherlands
| | | | | | - Jan A Mol
- Department of Clinical Sciences of Companion Animals, Utrecht University, Utrecht, The Netherlands
| | - Ger J Strous
- Center for Molecular Medicine, Cell Biology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Alexandre Mjj Bonvin
- Computational Structural Biology, Bijvoet Centre for Biomolecular Research, Faculty of Science, Department of Chemistry, Utrecht University, Utrecht, The Netherlands
| | - Mario van der Stelt
- Department of Molecular Physiology and Oncode Institute, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands
| | - Edwin Ja Veldhuizen
- Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Utrecht University, Utrecht, The Netherlands
| | - Markus Weingarth
- NMR Spectroscopy, Bijvoet Centre for Biomolecular Research, Department of Chemistry, Faculty of Science, Utrecht University, Utrecht, The Netherlands
| | - Michiel Vermeulen
- Department of Molecular Biology and Oncode Institute, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - Judith Klumperman
- Center for Molecular Medicine, Cell Biology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Madelon M Maurice
- Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands
| |
Collapse
|
3
|
Santhoshkumar AC, Durugappa B, Doddamani SV, Siby A, Valmiki PK, Somappa SB. Diastereoselective Synthesis of Fused Tricyclic Pyridopyrimidines via Tandem Cyclization of Allenoates and Cyclic Amidines. Org Lett 2023; 25:7711-7715. [PMID: 37843814 DOI: 10.1021/acs.orglett.3c03053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2023]
Abstract
The tandem cyclization of easily accessible allenoates and cyclic amidines for the synthesis of functionalized tricyclic pyridopyrimidines is reported herein. The annulation featured a broad substrate scope with good functional group tolerance under very mild conditions (35 examples, 32-85% yields). The pyridopyrimidines were obtained in a very short reaction time (1 min), at room temperature, under neat conditions, which offers an alternative way to the sustainable synthesis of functionalized pyridopyrimidines. The scalability of the developed protocol is further demonstrated by a gram-scale synthesis.
Collapse
Affiliation(s)
- Athira C Santhoshkumar
- Chemical Sciences & Technology Division, Council of Scientific and Industrial Research (CSIR)-National Institute for Interdisciplinary Science & Technology (NIIST), Thiruvananthapuram, Kerala 695019, India
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India
| | - Basavaraja Durugappa
- Chemical Sciences & Technology Division, Council of Scientific and Industrial Research (CSIR)-National Institute for Interdisciplinary Science & Technology (NIIST), Thiruvananthapuram, Kerala 695019, India
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India
| | - Siddalingeshwar V Doddamani
- Chemical Sciences & Technology Division, Council of Scientific and Industrial Research (CSIR)-National Institute for Interdisciplinary Science & Technology (NIIST), Thiruvananthapuram, Kerala 695019, India
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India
| | - Aiswarya Siby
- Chemical Sciences & Technology Division, Council of Scientific and Industrial Research (CSIR)-National Institute for Interdisciplinary Science & Technology (NIIST), Thiruvananthapuram, Kerala 695019, India
| | - Praveen K Valmiki
- Chemical Sciences & Technology Division, Council of Scientific and Industrial Research (CSIR)-National Institute for Interdisciplinary Science & Technology (NIIST), Thiruvananthapuram, Kerala 695019, India
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India
| | - Sasidhar B Somappa
- Chemical Sciences & Technology Division, Council of Scientific and Industrial Research (CSIR)-National Institute for Interdisciplinary Science & Technology (NIIST), Thiruvananthapuram, Kerala 695019, India
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India
| |
Collapse
|
4
|
Hammouda MM, Rashed MM, Elattar KM, Osman AMA. Synthetic strategies of heterocycle-integrated pyridopyrimidine scaffolds supported by nano-catalysts. RSC Adv 2023; 13:11600-11634. [PMID: 37063723 PMCID: PMC10103583 DOI: 10.1039/d3ra00922j] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Accepted: 03/29/2023] [Indexed: 04/18/2023] Open
Abstract
Nano-catalysts are of special character for the synthesis of organic molecules with high efficiency, and exceptional physicochemical properties. The objective of this study was to present an overview of the literature reports concerning the synthetic strategies supported by nano-catalysts and the biological features of heterocycle-integrated pyridopyrimidine scaffolds. The basic topics include the strategies that were adopted to prepare pyrido[2,3-d]pyrimidines and pyrido[1,2-a]pyrimidines. The synthesis of pyrido[2,3-d]pyrimidines was attained through two-, three-, or four-component reactions. The synthesis of spirocyclic systems, including spiro[indoline-pyridopyrimidine] derivatives and arylation reactions, was investigated. The anticipated mechanisms of the diverse target products, in addition to the preparation of the nanocatalysts, were scrutinized. The privileged antimicrobial characteristics, challenges, literature overview, and future prospectives were consistently investigated.
Collapse
Affiliation(s)
- Mohamed M Hammouda
- Department of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University Al-Kharj 11942 Saudi Arabia
- Chemistry Department, Faculty of Science, Mansoura University El-Gomhoria Street Mansoura 35516 Egypt
| | - Marwa M Rashed
- Toxicology Department, Mansoura Hospital, Faculty of Medicine, Mansoura University El-Gomhoria Street Mansoura 35516 Egypt
| | - Khaled M Elattar
- Unit of Genetic Engineering and Biotechnology, Faculty of Science, Mansoura University El-Gomhoria Street Mansoura 35516 Egypt +20-1010655354
| | - Amany M A Osman
- Department of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University Al-Kharj 11942 Saudi Arabia
- Chemistry Department, Faculty of Science, Menoufia University Shebin El-Koam Egypt
| |
Collapse
|
5
|
Elsayed GA, Mahmoud NFH. Synthesis and Biological Assessment of New Nucleosides of Pyrido[2,3-d]pyrimidine Derivatives Bearing Ribose and 2-Deoxyribose Moieties. Polycycl Aromat Compd 2022. [DOI: 10.1080/10406638.2022.2074476] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Galal A. Elsayed
- Synthetic Carbohydrates Laboratory, Chemistry Department, Faculty of Science, Ain Shams University, Abbassia, Cairo, Egypt
| | - Naglaa F. H. Mahmoud
- Synthetic Carbohydrates Laboratory, Chemistry Department, Faculty of Science, Ain Shams University, Abbassia, Cairo, Egypt
| |
Collapse
|
6
|
Dastmard S, Mamaghani M, Farahnak L, Rassa M. Facile Synthesis of Polyfunctional Indole-Pyrido[2,3- d]Pyrimidine Hybrids Using Nickel-Incorporated Fluorapatite Encapsulated Iron Oxide Nanocatalyst and Study of Their Antibacterial Activities. Polycycl Aromat Compd 2022. [DOI: 10.1080/10406638.2020.1804413] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- Sahar Dastmard
- Department of Chemistry, University of Guilan, Rasht, Iran
| | | | - Lahya Farahnak
- Department of Chemistry, University of Guilan, Rasht, Iran
| | - Mehdi Rassa
- Department of Biology, University of Guilan, Rasht, Iran
| |
Collapse
|
7
|
Abd-Elaziz AM, Aly HM, Saleh NM, Fouad SA, Ismail AA, Fouda A. Synthesis and characterization of the novel pyrimidine’s derivatives, as a promising tool for antimicrobial agent and in-vitro cytotoxicity. JOURNAL OF THE IRANIAN CHEMICAL SOCIETY 2021. [DOI: 10.1007/s13738-021-02448-w] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
8
|
Safajoo N, Mirjalili BBF, Bamoniri A. A Facile and Clean Synthesis of Indenopyrido[2,3- d]Pyrimidines in the Presence of Fe 3O 4@NCs/Cu(II) as Bio-Based Magnetic Nano-Catalyst. Polycycl Aromat Compd 2021. [DOI: 10.1080/10406638.2019.1666889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- Nasrin Safajoo
- Department of Chemistry, College of Science, Yazd University, Yazd, Iran
| | | | - Abdolhamid Bamoniri
- Department of Organic Chemistry, Faculty of Chemistry, University of Kashan, Kashan, Iran
| |
Collapse
|
9
|
Elsaedany SK, AbdEllatif zein M, AbdElRehim EM, Keshk RM. Synthesis and Biological Activity Studies of Novel Pyrido[2,3-d]pyrimidines and Pyrido[2,3-d]triazines. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY 2021. [DOI: 10.1134/s1068162021020114] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
10
|
Cuthbertson CR, Arabzada Z, Bankhead A, Kyani A, Neamati N. A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight. ACS Pharmacol Transl Sci 2021; 4:624-646. [PMID: 33860190 DOI: 10.1021/acsptsci.0c00223] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Indexed: 02/06/2023]
Abstract
Metabolic reprogramming is a key hallmark of cancer and shifts cellular metabolism to meet the demands of biomass production necessary for abnormal cell reproduction. One-carbon metabolism (1CM) contributes to many biosynthetic pathways that fuel growth and is comprised of a complex network of enzymes. Methotrexate and 5-fluorouracil were pioneering drugs in this field and are still widely used today as anticancer agents as well as for other diseases such as arthritis. Besides dihydrofolate reductase and thymidylate synthase, two other enzymes of the folate cycle arm of 1CM have not been targeted clinically: serine hydroxymethyltransferase (SHMT) and methylenetetrahydrofolate dehydrogenase (MTHFD). An increasing body of literature suggests that the mitochondrial isoforms of these enzymes (SHMT2 and MTHFD2) are clinically relevant in the context of cancer. In this review, we focused on the 1CM pathway as a target for cancer therapy and, in particular, SHMT2 and MTHFD2. The function, regulation, and clinical relevance of SHMT2 and MTHFD2 are all discussed. We expand on previous clinical studies and evaluate the prognostic significance of these critical enzymes by performing a pan-cancer analysis of patient data from the The Cancer Genome Atlas and a transcriptional coexpression network enrichment analysis. We also provide an overview of preclinical and clinical inhibitors targeting the folate pathway, the methionine cycle, and folate-dependent purine biosynthesis enzymes.
Collapse
Affiliation(s)
- Christine R Cuthbertson
- Department of Medicinal Chemistry, College of Pharmacy and the Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States
| | - Zahra Arabzada
- Department of Medicinal Chemistry, College of Pharmacy and the Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States
| | - Armand Bankhead
- Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan 48109, United States.,Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States
| | - Armita Kyani
- Department of Medicinal Chemistry, College of Pharmacy and the Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States
| | - Nouri Neamati
- Department of Medicinal Chemistry, College of Pharmacy and the Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States
| |
Collapse
|
11
|
Mohamed MAM, Abdel-Hafez SH, Gobouri AA. Nucleosides 11: synthesis of new derivatives of pyrido[2,3- d]pyrimidines and their nucleosides. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2020; 40:222-232. [PMID: 33380257 DOI: 10.1080/15257770.2020.1862869] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
Reaction of 6-amino-2-methylthio-3-methyluracil with ethyl ethoxymethyleneoxaloacetate or methyl(Z)-2-acetylamino-3-dimethylaminopropenoates afforded diethyl 2-(1,6-dihydro-1-methyl-2-(methylthio)-6-oxopyrimidin-4-yl-amino)methylene malonate or (2E)-methyl 3-(1,6-dihydro-1-methyl-2-(methylthio)-6-oxopyrimidin-4-yl-amino)-2-acetamidoacrylate, respectively. Cyclization of each of the latter products by sodium ethoxide afforded new pyrido [2,3-d]pyrimidines, which were ribosylated with 1-O-acetyl-2,3,5-O-benzoyl-β-D-ribofuranose by the silylation method yielded the protected nucleosides. The protected nucleosides were debenzoylated by sodium methoxide to afford novel pyrido[2,3-d]pyrimidine nucleosides. The structural assignmentsv for the new compounds were based on their elemental analysis and spectroscopic data.
Collapse
Affiliation(s)
| | - Shams H Abdel-Hafez
- Department of Chemistry, College of Science, Taif University, Taif, Saudi Arabia
| | - Adil A Gobouri
- Department of Chemistry, College of Science, Taif University, Taif, Saudi Arabia
| |
Collapse
|
12
|
Hassan AY, Sarg MT, El‐Sebaey SA. Synthesis and antitumor evaluation of some new derivatives and fused heterocyclic compounds derived from thieno[2,3‐
b
]pyridine: Part 2. J Heterocycl Chem 2019. [DOI: 10.1002/jhet.3810] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Aisha Y. Hassan
- Department of Chemistry, Faculty of Science (Girls)Al‐Azhar University Nasr City Cairo Egypt
| | - Marwa T. Sarg
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Girls)Al‐Azhar University Nasr City Cairo Egypt
| | - Samiha A. El‐Sebaey
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Girls)Al‐Azhar University Nasr City Cairo Egypt
| |
Collapse
|
13
|
Assy MG, El‐Sayed HA, Ouf NH, Hamza A, Morsy HA. Cycloaddition of Aroyl Isothiocyanate: A Novel Synthesis of Triazine, Oxazine, Pyrimidine, and Pyridine Derivatives. J Heterocycl Chem 2019. [DOI: 10.1002/jhet.3690] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Mohamed G. Assy
- Chemistry Department, Faculty of ScienceZagazig University Zagazig 44519 Egypt
| | - Hassan A. El‐Sayed
- Chemistry Department, Faculty of ScienceZagazig University Zagazig 44519 Egypt
| | - Nabil H. Ouf
- Chemistry Department, Faculty of ScienceZagazig University Zagazig 44519 Egypt
| | - Ahmed Hamza
- Chemistry Department, Faculty of ScienceZagazig University Zagazig 44519 Egypt
- Department of Chemistry, Faculty of ScienceAl‐furat Al‐Awsat Technical University Kufa Iraq
| | - Hesham A. Morsy
- Higher Institution of Engineering & Modern Technology Elmarg‐Cairo Egypt
| |
Collapse
|
14
|
Cyclic acyl amidines as unexpected C4-donors for fully substituted pyridine ring formation in the base mediated reaction with malononitrile. Tetrahedron Lett 2019. [DOI: 10.1016/j.tetlet.2019.06.038] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
15
|
Toulouse J, Yachnin BJ, Ruediger EH, Deon D, Gagnon M, Saint-Jacques K, Ebert MCCC, Forge D, Bastien D, Colin DY, Vanden Eynde JJ, Marinier A, Berghuis AM, Pelletier JN. Structure-Based Design of Dimeric Bisbenzimidazole Inhibitors to an Emergent Trimethoprim-Resistant Type II Dihydrofolate Reductase Guides the Design of Monomeric Analogues. ACS OMEGA 2019; 4:10056-10069. [PMID: 31460098 PMCID: PMC6648814 DOI: 10.1021/acsomega.9b00640] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/07/2019] [Accepted: 05/22/2019] [Indexed: 05/18/2023]
Abstract
The worldwide use of the broad-spectrum antimicrobial trimethoprim (TMP) has induced the rise of TMP-resistant microorganisms. In addition to resistance-causing mutations of the microbial chromosomal dihydrofolate reductase (Dfr), the evolutionarily and structurally unrelated type II Dfrs (DfrBs) have been identified in TMP-resistant microorganisms. DfrBs are intrinsically TMP-resistant and allow bacterial proliferation when the microbial chromosomal Dfr is TMP-inhibited, making these enzymes important targets for inhibitor development. Furthermore, DfrBs occur in multiresistance plasmids, potentially accelerating their dissemination. We previously reported symmetrical bisbenzimidazoles that are the first selective inhibitors of the only well-characterized DfrB, DfrB1. Here, their diversification provides a new series of inhibitors (K i = 1.7-12.0 μM). Our results reveal two prominent features: terminal carboxylates and inhibitor length allow the establishment of essential interactions with DfrB1. Two crystal structures demonstrate the simultaneous binding of two inhibitor molecules in the symmetrical active site. Observations of those dimeric inhibitors inspired the design of monomeric analogues, binding in a single copy yet offering similar inhibition potency (K i = 1.1 and 7.4 μM). Inhibition of a second member of the DfrB family, DfrB4, suggests the generality of these inhibitors. These results provide key insights into inhibition of the highly TMP-resistant DfrBs, opening avenues to downstream development of antibiotics for combatting this emergent source of resistance.
Collapse
Affiliation(s)
- Jacynthe
L. Toulouse
- Département
de Biochimie, Institute for Research in Immunology and Cancer
(IRIC), and Département de Chimie, Université
de Montréal, Montreal H3C 3J7, Quebec, Canada
- PROTEO,
the Québec Network for Research on Protein, Function, Engineering
and Applications, Quebec G1V 0A6, Canada
- CGCC,
The Center in Green Chemistry and Catalysis, Montréal H3A
0B8, Quebec, Canada
| | - Brahm J. Yachnin
- PROTEO,
the Québec Network for Research on Protein, Function, Engineering
and Applications, Quebec G1V 0A6, Canada
- Department
of Biochemistry, McGill University, Montréal H3A 0G4, Quebec, Canada
| | - Edward H. Ruediger
- Département
de Biochimie, Institute for Research in Immunology and Cancer
(IRIC), and Département de Chimie, Université
de Montréal, Montreal H3C 3J7, Quebec, Canada
| | - Daniel Deon
- Département
de Biochimie, Institute for Research in Immunology and Cancer
(IRIC), and Département de Chimie, Université
de Montréal, Montreal H3C 3J7, Quebec, Canada
| | - Marc Gagnon
- Département
de Biochimie, Institute for Research in Immunology and Cancer
(IRIC), and Département de Chimie, Université
de Montréal, Montreal H3C 3J7, Quebec, Canada
| | - Kévin Saint-Jacques
- Département
de Biochimie, Institute for Research in Immunology and Cancer
(IRIC), and Département de Chimie, Université
de Montréal, Montreal H3C 3J7, Quebec, Canada
- Département
de Chimie, Université de Sherbrooke, Sherbrooke J1K 0A5, Quebec, Canada
| | | | - Delphine Forge
- Laboratoire
de Chimie Organique, Université de
Mons, Mons 7000, Belgium
| | - Dominic Bastien
- Département
de Biochimie, Institute for Research in Immunology and Cancer
(IRIC), and Département de Chimie, Université
de Montréal, Montreal H3C 3J7, Quebec, Canada
- PROTEO,
the Québec Network for Research on Protein, Function, Engineering
and Applications, Quebec G1V 0A6, Canada
- CGCC,
The Center in Green Chemistry and Catalysis, Montréal H3A
0B8, Quebec, Canada
| | - Damien Y. Colin
- Département
de Biochimie, Institute for Research in Immunology and Cancer
(IRIC), and Département de Chimie, Université
de Montréal, Montreal H3C 3J7, Quebec, Canada
- PROTEO,
the Québec Network for Research on Protein, Function, Engineering
and Applications, Quebec G1V 0A6, Canada
- CGCC,
The Center in Green Chemistry and Catalysis, Montréal H3A
0B8, Quebec, Canada
| | | | - Anne Marinier
- Département
de Biochimie, Institute for Research in Immunology and Cancer
(IRIC), and Département de Chimie, Université
de Montréal, Montreal H3C 3J7, Quebec, Canada
| | - Albert M. Berghuis
- PROTEO,
the Québec Network for Research on Protein, Function, Engineering
and Applications, Quebec G1V 0A6, Canada
- Department
of Biochemistry, McGill University, Montréal H3A 0G4, Quebec, Canada
| | - Joelle N. Pelletier
- Département
de Biochimie, Institute for Research in Immunology and Cancer
(IRIC), and Département de Chimie, Université
de Montréal, Montreal H3C 3J7, Quebec, Canada
- PROTEO,
the Québec Network for Research on Protein, Function, Engineering
and Applications, Quebec G1V 0A6, Canada
- CGCC,
The Center in Green Chemistry and Catalysis, Montréal H3A
0B8, Quebec, Canada
- E-mail: . Phone: 514-343-2124. Fax: 514-343-7586
| |
Collapse
|
16
|
Afrough T, Bakavoli M, Eshghi H. A New Multicomponent Synthetic Route to Hexahydropyrido[2,3-d
]pyrimidine Derivatives. J Heterocycl Chem 2019. [DOI: 10.1002/jhet.3441] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Affiliation(s)
- Toktam Afrough
- Department of Chemistry, Faculty of Science; Ferdowsi University of Mashhad; Mashhad 91775-1436 Iran
| | - Mehdi Bakavoli
- Department of Chemistry, Faculty of Science; Ferdowsi University of Mashhad; Mashhad 91775-1436 Iran
| | - Hossein Eshghi
- Department of Chemistry, Faculty of Science; Ferdowsi University of Mashhad; Mashhad 91775-1436 Iran
| |
Collapse
|
17
|
Banda V, Gaddameedi Jitender D, Gautham Santhosh K, Pillalamarri Sambasiva R, Chavva K, Rajesh P, Janapala Venkateswara R, Banda N. Studies on Synthesis of Novel Pyrido[2,3- d
] pyrimidine Derivatives and Their Anticancer Activity. J Heterocycl Chem 2018. [DOI: 10.1002/jhet.3307] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Veeraswamy Banda
- Fluoroorganics Division; Indian Institute of Chemical Technology; Tarnaka Hyderabad Telangana 500007 India
| | - Dev Gaddameedi Jitender
- Fluoroorganics Division; Indian Institute of Chemical Technology; Tarnaka Hyderabad Telangana 500007 India
| | - Kumar Gautham Santhosh
- Fluoroorganics Division; Indian Institute of Chemical Technology; Tarnaka Hyderabad Telangana 500007 India
| | - Rao Pillalamarri Sambasiva
- Fluoroorganics Division; Indian Institute of Chemical Technology; Tarnaka Hyderabad Telangana 500007 India
| | - Kurumurthy Chavva
- Fluoroorganics Division; Indian Institute of Chemical Technology; Tarnaka Hyderabad Telangana 500007 India
| | - Pamanji Rajesh
- Biology Division; Indian Institute of Chemical Technology; Hyderabad Telangana 500 007 India
| | | | - Narsaiah Banda
- Fluoroorganics Division; Indian Institute of Chemical Technology; Tarnaka Hyderabad Telangana 500007 India
| |
Collapse
|
18
|
Green metal-free synthesis of spiro-fused 3,4′-pyrazolo[4′,3′:5,6]pyrido[2,3-d]pyrimidine derivatives via deamination cyclization reactions in aqueous medium. RESEARCH ON CHEMICAL INTERMEDIATES 2018. [DOI: 10.1007/s11164-018-3642-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
19
|
One-pot chemoselective synthesis of novel pyrrole-substituted pyrido [2,3- d ]pyrimidines using [γ-Fe 2 O 3 @HAp-SO 3 H] as an efficient nanocatalyst. J Mol Struct 2018. [DOI: 10.1016/j.molstruc.2017.11.034] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
20
|
Mamaghani M, Sheykhan M, Sadeghpour M, Tavakoli F. An expeditious one-pot synthesis of novel bioactive indole-substituted pyrido[2,3-d]pyrimidines using Fe3O4@SiO2-supported ionic liquid nanocatalyst. MONATSHEFTE FUR CHEMIE 2018. [DOI: 10.1007/s00706-018-2166-2] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
21
|
AbedelRehim EM, AbdEllatif M. Synthesis of Some Novel Pyrido[2,3-d
]pyrimidine and Pyrido[3,2-e
][1,3,4]triazolo and Tetrazolo[1,5-c
]pyrimidine Derivatives as Potential Antimicrobial and Anticancer Agents. J Heterocycl Chem 2017. [DOI: 10.1002/jhet.3058] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
| | - Mohamed AbdEllatif
- Chemistry Department, Faculty of Science; Damanhour University; Damanhour Egypt
| |
Collapse
|
22
|
Wang Y, Zhou L, Zhu Y, Zhang M, Song L, Deng H. Unexpected straightforward formation of trifluoromethylated pyrido[2,3- d ]pyrimidine derivatives via one-pot, MCRs. J Fluor Chem 2017. [DOI: 10.1016/j.jfluchem.2017.06.016] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
23
|
Tetrachlorosilane and zinc chloride as a binary reagent for the preparation of 2-amino-6-chloropyridine-3,5-dicarbonitrile derivatives. Chem Heterocycl Compd (N Y) 2017. [DOI: 10.1007/s10593-017-2089-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
24
|
Zaware N, Kisliuk R, Bastian A, Ihnat MA, Gangjee A. Synthesis and evaluation of 5-(arylthio)-9H-pyrimido[4,5-b]indole-2,4-diamines as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents. Bioorg Med Chem Lett 2017; 27:1602-1607. [PMID: 28258797 PMCID: PMC5398096 DOI: 10.1016/j.bmcl.2017.02.018] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2016] [Revised: 02/07/2017] [Accepted: 02/08/2017] [Indexed: 02/05/2023]
Abstract
In an effort to optimize the structural requirements for combined cytostatic and cytotoxic effects in single agents, a series of 5-(arylthio)-9H-pyrimido[4,5-b]indole-2,4-diamines 3-7 were synthesized and evaluated as inhibitors of receptor tyrosine kinases (RTKs) as well as thymidylate synthase (TS). The synthesis of these compounds involved the nucleophilic displacement of the common intermediate 5-bromo/5-chloro-9H-pyrimido[4,5-b]indole-2,4-diamine with appropriate aryl thiols. A novel four step synthetic scheme to the common intermediate was developed which is more efficient relative to the previously reported six-step sequence. Biological evaluation of these compounds indicated dual activity in RTKs and human TS (hTS). In the VEGFR-2 assay, compound 5 was equipotent to the standard compound semaxanib and was better than standard TS inhibitor pemetrexed, in the hTS assay. Compounds 3, 6 and 7 were nanomolar inhibitors of hTS and were several fold better than pemetrexed.
Collapse
Affiliation(s)
- Nilesh Zaware
- Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, 600 Forbes Avenue, Pittsburgh, PA 15282, United States
| | - Roy Kisliuk
- Department of Biochemistry, Tufts University School of Medicine, Boston, MA 02111, United States
| | - Anja Bastian
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, United States
| | - Michael A Ihnat
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, United States
| | - Aleem Gangjee
- Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, 600 Forbes Avenue, Pittsburgh, PA 15282, United States.
| |
Collapse
|
25
|
Mamaghani M, Hossein Nia R. Recent Developments in the MCRs Synthesis of Pyridopyrimidines and Spiro‐Pyridopyrimidines. J Heterocycl Chem 2016. [DOI: 10.1002/jhet.2783] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Manouchehr Mamaghani
- Department of Chemistry, Faculty of SciencesUniversity of Guilan P.O. Box 41335‐1914 Rasht Iran
| | - Roghayeh Hossein Nia
- Department of Chemistry, Faculty of SciencesUniversity of Guilan P.O. Box 41335‐1914 Rasht Iran
| |
Collapse
|
26
|
Naresh Kumar R, Jitender Dev G, Ravikumar N, Krishna Swaroop D, Debanjan B, Bharath G, Narsaiah B, Nishant Jain S, Gangagni Rao A. Synthesis of novel triazole/isoxazole functionalized 7-(trifluoromethyl)pyrido[2,3- d ]pyrimidine derivatives as promising anticancer and antibacterial agents. Bioorg Med Chem Lett 2016; 26:2927-2930. [DOI: 10.1016/j.bmcl.2016.04.038] [Citation(s) in RCA: 42] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2015] [Revised: 04/04/2016] [Accepted: 04/15/2016] [Indexed: 10/21/2022]
|
27
|
Acosta P, Insuasty B, Ortiz A, Abonia R, Sortino M, Zacchino SA, Quiroga J. Solvent-free microwave-assisted synthesis of novel pyrazolo[4′,3′:5,6]pyrido[2,3-d]pyrimidines with potential antifungal activity. ARAB J CHEM 2016. [DOI: 10.1016/j.arabjc.2015.03.002] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
28
|
Mohana Roopan S, Sompalle R. Synthetic chemistry of pyrimidines and fused pyrimidines: A review. SYNTHETIC COMMUN 2016. [DOI: 10.1080/00397911.2016.1165254] [Citation(s) in RCA: 49] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
29
|
Mamaghani M, Taati Z, Rasoulian M, Yousefizad J, Toraji N, Mohsenimehr M, Nia RH. [γ-Fe2O3@HAp-SO3H] an Efficient Nanocatalyst for the Synthesis of Highly Functionalised 2-thioxopyrido[2,3-d]Pyrimidines. JOURNAL OF CHEMICAL RESEARCH 2016. [DOI: 10.3184/174751916x14495860660659] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
HAp(hydroxyapatite)-encapsulated-γ-Fe2O3 supported sulfonic acid nanoparticles were used for the preparation of two series of 2-thioxopyrido[2,3-d]pyrimidines. In the first series, 2-thioxopyrido[2,3-d]pyrimidines were synthesised from 3-(6-amino-1,2,3,4-tetrahydro-4-oxo-2-thioxopyrimidin-5-yl)-3-oxopropanenitrile and arylaldehydes in the presence of [γ-Fe2O3@HAp-SO3H] as a nanocatalyst, in high yields (84–96%). In the second series, [γ-Fe2O3@HAp-SO3H] was used to catalyse the reaction of 6-amino-2-(alkylthio)-pyrimidine-4,6(1H,5H)-dione, 1,3-diethyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione and various arylaldehydes to prepare 2-thioxo-2,3,7,10-tetrahydropyrido[2,3-d:5,6-d']dipyrimidine-4,6 (1H,5H)-diones in excellent yields (93–98%).
Collapse
Affiliation(s)
- Manouchehr Mamaghani
- Department of Chemistry, Faculty of Sciences, University of Guilan, PO Box 41335-1914, Rasht, Iran
- Department of Chemistry, Faculty of Sciences, Islamic Azad University, Rasht Branch, PO Box 41335-3516, Rasht, Iran
| | - Zahra Taati
- Department of Chemistry, Faculty of Sciences, University of Guilan, PO Box 41335-1914, Rasht, Iran
| | - Mona Rasoulian
- Department of Chemistry, Faculty of Sciences, University of Guilan, PO Box 41335-1914, Rasht, Iran
| | - Javad Yousefizad
- Department of Chemistry, Faculty of Sciences, Islamic Azad University, Rasht Branch, PO Box 41335-3516, Rasht, Iran
| | - Nooshin Toraji
- Department of Chemistry, Faculty of Sciences, Islamic Azad University, Rasht Branch, PO Box 41335-3516, Rasht, Iran
| | - Mona Mohsenimehr
- Department of Chemistry, Faculty of Sciences, University of Guilan, PO Box 41335-1914, Rasht, Iran
| | - Roghayeh Hossein Nia
- Department of Chemistry, Faculty of Sciences, University of Guilan, PO Box 41335-1914, Rasht, Iran
| |
Collapse
|
30
|
A new and efficient ZnCl2-catalyzed synthesis and biological evaluation of novel 2-amino-3,5-dicyano-4-aryl-6-aryl-aminopyridines as potent antibacterial agents against Helicobacter pylori (HP). Tetrahedron 2015. [DOI: 10.1016/j.tet.2015.09.018] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
|
31
|
Belhadj F, Kibou Z, Cheikh N, Choukchou-Braham N, Villemin D. Convenient access to new 4-substituted aminopyrido[2,3-d]pyrimidine derivatives. Tetrahedron Lett 2015. [DOI: 10.1016/j.tetlet.2015.09.042] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
32
|
Elsaedany SK, AbdEllatif Zein M, AbedelRehim EM, Keshk RM. Synthesis, Anti-Microbial, and Cytotoxic Activities Evaluation of Some New Pyrido[2,3-d]Pyrimidines. J Heterocycl Chem 2015. [DOI: 10.1002/jhet.2460] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Samir Kamel Elsaedany
- Department of Chemistry, Faculty of Science; Alexandria University; Alexandria Egypt
| | | | | | - Reda Mohammed Keshk
- Department of Chemistry, Faculty of Science; Damnhour University; Damnhour Egypt
| |
Collapse
|
33
|
Bautista-Aguilera OM, Esteban G, Chioua M, Nikolic K, Agbaba D, Moraleda I, Iriepa I, Soriano E, Samadi A, Unzeta M, Marco-Contelles J. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids. DRUG DESIGN DEVELOPMENT AND THERAPY 2014; 8:1893-910. [PMID: 25378907 PMCID: PMC4207550 DOI: 10.2147/dddt.s69258] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
The design, synthesis, and biochemical evaluation of donepezil-pyridyl hybrids (DPHs) as multipotent cholinesterase (ChE) and monoamine oxidase (MAO) inhibitors for the potential treatment of Alzheimer’s disease (AD) is reported. The 3D-quantitative structure-activity relationship study was used to define 3D-pharmacophores for inhibition of MAO A/B, acetylcholinesterase (AChE), and butyrylcholinesterase (BuChE) enzymes and to design DPHs as novel multi-target drug candidates with potential impact in the therapy of AD. DPH14 (Electrophorus electricus AChE [EeAChE]: half maximal inhibitory concentration [IC50] =1.1±0.3 nM; equine butyrylcholinesterase [eqBuChE]: IC50 =600±80 nM) was 318-fold more potent for the inhibition of AChE, and 1.3-fold less potent for the inhibition of BuChE than the reference compound ASS234. DPH14 is a potent human recombinant BuChE (hBuChE) inhibitor, in the same range as DPH12 or DPH16, but 13.1-fold less potent than DPH15 for the inhibition of human recombinant AChE (hAChE). Compared with donepezil, DPH14 is almost equipotent for the inhibition of hAChE, and 8.8-fold more potent for hBuChE. Concerning human monoamine oxidase (hMAO) A inhibition, only DPH9 and 5 proved active, compound DPH9 being the most potent (IC50 [MAO A] =5,700±2,100 nM). For hMAO B, only DPHs 13 and 14 were moderate inhibitors, and compound DPH14 was the most potent (IC50 [MAO B] =3,950±940 nM). Molecular modeling of inhibitor DPH14 within EeAChE showed a binding mode with an extended conformation, interacting simultaneously with both catalytic and peripheral sites of EeAChE thanks to a linker of appropriate length. Absortion, distribution, metabolism, excretion and toxicity analysis showed that structures lacking phenyl-substituent show better druglikeness profiles; in particular, DPHs13–15 showed the most suitable absortion, distribution, metabolism, excretion and toxicity properties. Novel donepezil-pyridyl hybrid DPH14 is a potent, moderately selective hAChE and selective irreversible hMAO B inhibitor which might be considered as a promising compound for further development for the treatment of AD.
Collapse
Affiliation(s)
- Oscar M Bautista-Aguilera
- Laboratory of Medicinal Chemistry (Institute of General Organic Chemistry [IQOG], National Research Council [CSIC]), Madrid, Spain
| | - Gerard Esteban
- Department of Biochemistry and Molecular Biology, Institute of Neurosciences, Autonomous Barcelona University, Barcelona, Spain
| | - Mourad Chioua
- Laboratory of Medicinal Chemistry (Institute of General Organic Chemistry [IQOG], National Research Council [CSIC]), Madrid, Spain
| | - Katarina Nikolic
- Institute of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
| | - Danica Agbaba
- Institute of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
| | - Ignacio Moraleda
- Department of Organic Chemistry, Faculty of Pharmacy, University of Alcalá, Ctra Barcelona, Alcalá de Henares, Spain
| | - Isabel Iriepa
- Department of Organic Chemistry, Faculty of Pharmacy, University of Alcalá, Ctra Barcelona, Alcalá de Henares, Spain
| | - Elena Soriano
- Synthesis, and Structure of Organic Compounds (SEPCO) (IQOG, CSIC), Madrid, Spain
| | - Abdelouahid Samadi
- Laboratory of Medicinal Chemistry (Institute of General Organic Chemistry [IQOG], National Research Council [CSIC]), Madrid, Spain
| | - Mercedes Unzeta
- Department of Biochemistry and Molecular Biology, Institute of Neurosciences, Autonomous Barcelona University, Barcelona, Spain
| | - José Marco-Contelles
- Laboratory of Medicinal Chemistry (Institute of General Organic Chemistry [IQOG], National Research Council [CSIC]), Madrid, Spain
| |
Collapse
|
34
|
Mohsenimehr M, Mamaghani M, Shirini F, Sheykhan M, Moghaddam FA. One-pot synthesis of novel pyrido[2,3-d]pyrimidines using HAp-encapsulated-γ-Fe2O3 supported sulfonic acid nanocatalyst under solvent-free conditions. CHINESE CHEM LETT 2014. [DOI: 10.1016/j.cclet.2014.04.025] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
35
|
Kayukov YS, Karpov SV, Kayukova OV, Ershov OV, Nasakin OE. 2-Acyl(aroyl)-1,1,3,3-tetracyanopropenides: VI. Reaction with hydrogen halides. RUSSIAN JOURNAL OF ORGANIC CHEMISTRY 2014. [DOI: 10.1134/s1070428014080053] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
36
|
Chioua M, Samadi A, Soriano E, Infantes L, Marco-Contelles J. Silver Triflate-Catalyzed Cyclization of 2-Amino-6-propargyl- amineazines Leading to Iminoimidazoazines. Adv Synth Catal 2014. [DOI: 10.1002/adsc.201300799] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
37
|
Kosurkar UB, Dadmal TL, Appalanaidu K, Khageswara Rao Y, Nanubolu JB, Kumbhare RM. Microwave assisted synthesis of 2-aminooxazolo [4,5-b] pyridine derivatives via intramolecular C–O bond formation in aqueous medium. Tetrahedron Lett 2014. [DOI: 10.1016/j.tetlet.2013.12.090] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
38
|
Yang L, Li J, Chai H, Lu H, Zhang Q, Shi D. A Divergent Synthesis of 1,8-Naphthyridines and Hydropyridopyrimidinones by the Reactions ofo-Aminonitriles with Ketones. CHINESE J CHEM 2013. [DOI: 10.1002/cjoc.201201247] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
39
|
Samadi A, Estrada M, Pérez C, Rodríguez-Franco MI, Iriepa I, Moraleda I, Chioua M, Marco-Contelles J. Pyridonepezils, new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease: synthesis, biological assessment, and molecular modeling. Eur J Med Chem 2012; 57:296-301. [PMID: 23078965 DOI: 10.1016/j.ejmech.2012.09.030] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2012] [Revised: 09/20/2012] [Accepted: 09/24/2012] [Indexed: 11/17/2022]
Abstract
The synthesis, biological assessment and molecular modeling of new pyridonepezils1-8, able to inhibit human acetylcholinesterase (hAChE) and human butyrylcholinesterase (hBuChE), are described. The new compounds have been designed as hybrids resulting from a conjunctive approach that combines the N-benzylpiperidine moiety, present in donepezil, and the 2-amino-6-chloropyridine heterocyclic ring system, connected by an appropriate polymethylene linker. Compounds 1-8 were prepared by reaction of 2-amino-6-chloro-4-phenylpyridine-3,5-dicarbonitrile (13) [or 2-amino-6-chloropyridine-3,5-dicarbonitrile (14)] with 2-(1-benzylpiperidin-4-yl)alkylamines (9-12). The biological evaluation of molecules 1-8 showed that compounds 1-6 are potent AChE inhibitors, in the submicromolar, while compounds 7 and 8 are on the nanomolar range, the most potent, 2-amino-6-((3-(1-benzylpiperidin-4-yl)propyl)amino)pyridine-3,5-dicarbonitrile (7), showing a IC(50) (hAChE) = 9.4 ± 0.4 nM. Inhibitors 2-8 are permeable as determined in the PAMPA assay. Compared to donepezil, compound 7 is in the same range of inhibitory activity for hAChE, and 703-fold more selective for hAChE than for hBuChE. Molecular modeling investigation on pyridonepezil7 supports its dual AChE inhibitory profile, binding simultaneously at the catalytic active and at peripheral anionic sites of the enzyme. The theoretical ADME analysis of pyridonepezils1-8 has been carried out. Overall, compound 7, a potent and selective dual AChEI, can be considered as a candidate with potential impact for further pharmacological development in Alzheimer's therapy.
Collapse
Affiliation(s)
- Abdelouahid Samadi
- Laboratorio de Química Médica, Instituto de Química Orgánica General (CSIC), C/Juan de la Cierva 3, 28006 Madrid, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
40
|
Koteswara Rao V, Hari Babu B, Raveendra Babu K, Srinivasulu D, Naga Raju C. EcoFriendly Synthesis of Tetrahydropyrimidine Derivatives in Aqueous Medium Under Ultrasonic Irradiation. SYNTHETIC COMMUN 2012. [DOI: 10.1080/00397911.2011.582218] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
41
|
Samadi A, de los Ríos C, Bolea I, Chioua M, Iriepa I, Moraleda I, Bartolini M, Andrisano V, Gálvez E, Valderas C, Unzeta M, Marco-Contelles J. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine. Eur J Med Chem 2012; 52:251-62. [DOI: 10.1016/j.ejmech.2012.03.022] [Citation(s) in RCA: 51] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2012] [Revised: 03/12/2012] [Accepted: 03/13/2012] [Indexed: 10/28/2022]
|
42
|
Wang X, Liang J, Quan Z, Bai L. Molecular Iodine Promoted Synthesis of New Pyrido[2,3-d]pyrimidin-4-ols. CHINESE J CHEM 2011. [DOI: 10.1002/cjoc.201180294] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
43
|
Kurumurthy C, Sambasiva Rao P, Veera swamy B, Santhosh kumar G, Shanthan Rao P, Narsaiah B, Velatooru L, Pamanji R, Venkateswara Rao J. Synthesis of novel alkyltriazole tagged pyrido[2,3-d]pyrimidine derivatives and their anticancer activity. Eur J Med Chem 2011; 46:3462-8. [DOI: 10.1016/j.ejmech.2011.05.011] [Citation(s) in RCA: 62] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2011] [Revised: 05/03/2011] [Accepted: 05/04/2011] [Indexed: 10/18/2022]
|
44
|
Baharfar R, Azimi R. A clean and efficient cyclocondensation to pyrido[2,3-d]pyrimidine derivatives in aqueous media. CHINESE CHEM LETT 2011. [DOI: 10.1016/j.cclet.2011.04.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
45
|
Shiri M, Zolfigol MA, Kruger HG, Tanbakouchian Z. Friedländer Annulation in the Synthesis of Azaheterocyclic Compounds. ADVANCES IN HETEROCYCLIC CHEMISTRY 2011. [DOI: 10.1016/b978-0-12-385464-3.00002-9] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
|
46
|
Sucunza D, Samadi A, Chioua M, Silva DB, Yunta C, Infantes L, Carmo Carreiras M, Soriano E, Marco-Contelles J. A practical two-step synthesis of imidazo[1,2-a]pyridines from N-(prop-2-yn-1-yl)pyridin-2-amines. Chem Commun (Camb) 2011; 47:5043-5. [DOI: 10.1039/c1cc10641d] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
47
|
da Silva DB, Samadi A, Infantes L, Carreiras MDC, Marco-Contelles J. Synthesis of (E)-diethyl 6,6′-(diazene-1,2-diyl)bis(5-cyano-2-methyl-4-phenylnicotinates), a new type of 2,2′-azopyridine dyes. Tetrahedron Lett 2010. [DOI: 10.1016/j.tetlet.2010.09.095] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
48
|
Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles. Bioorg Med Chem 2010; 18:5861-72. [DOI: 10.1016/j.bmc.2010.06.095] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2010] [Revised: 06/22/2010] [Accepted: 06/29/2010] [Indexed: 11/21/2022]
|
49
|
Chioua M, Samadi A, Soriano E, Lozach O, Meijer L, Marco-Contelles J. Synthesis and biological evaluation of 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors. Bioorg Med Chem Lett 2009; 19:4566-9. [PMID: 19615897 DOI: 10.1016/j.bmcl.2009.06.099] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2009] [Revised: 06/29/2009] [Accepted: 06/30/2009] [Indexed: 12/15/2022]
Abstract
The synthesis and biological evaluation of a number of differently substituted 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives are reported. From the inhibition results on a selection of disease-relevant protein kinases [IC(50) (microM) DYRK1A=11; CDK5=0.41; GSK-3=1.5] we have observed that 3,6-diamino-4-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile (4) constitutes a potential new and simple lead compound in the search of drugs for the treatment of Alzheimer's disease.
Collapse
Affiliation(s)
- Mourad Chioua
- Laboratorio de Radicales Libres y Química Computacional (IQOG, CSIC), 28006 Madrid, Spain
| | | | | | | | | | | |
Collapse
|
50
|
El-Gazzar ARB, Hafez HN. Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents. Bioorg Med Chem Lett 2009; 19:3392-7. [DOI: 10.1016/j.bmcl.2009.05.044] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2009] [Revised: 04/23/2009] [Accepted: 05/12/2009] [Indexed: 02/02/2023]
|